PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
19-Apr-2023 USA Animal Model Market is expected to reach US$ 1.4 Billion by the end of 2032 | FMI Study MARKITWIRED
19-Apr-2023 Viscosupplementation Market is projected to close in on a valuation of US$ 2.89 Billion by 2030 | MARKITWIRED
19-Apr-2023 Grünenthal GmbH: Grünenthal announces pricing of €300 million bond Grünenthal GmbH
19-Apr-2023 USA Skilled Nursing Facility Market | Genesis Healthcare, Brookdale Senior Living Solutions, The Ensign Group Inc, Extendicare | By 2032 MARKITWIRED
19-Apr-2023 Marinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023 Marinomed Biotech AG
19-Apr-2023 PharmaSGP plans dividend distribution of 49.2% after record year in 2022 PharmaSGP Holding SE
19-Apr-2023 Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials Alfa Chemistry
19-Apr-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Infosys Limited (INFY) on Behalf of Investors Businesswire
19-Apr-2023 ePharmacy Market is anticipated to reach US$ 92.4 billion in 2023 | Get Insights FMI MARKITWIRED
19-Apr-2023 Over-The-Counter (OTC) Veterinary Drugs Market size is estimated to cross US$ 18.14 Billion by 2032 | FMI MARKITWIRED
19-Apr-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Plug Power Inc. (PLUG) on Behalf of Investors Businesswire
18-Apr-2023 Carbios 加速酶優化進程,一天可檢測數百萬種酶 Businesswire
18-Apr-2023 Carbios加速酶优化过程,一天可筛选数百万种酶 Businesswire
18-Apr-2023 MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting Businesswire
18-Apr-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Spirit AeroSystems Holdings, Inc. (SPR) on Behalf of Investors Businesswire
18-Apr-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Alvotech (ALVO) on Behalf of Investors Businesswire
18-Apr-2023 Palleon Pharmaceuticals Presents Initial Phase 1 Results from the GLIMMER-01 Clinical Trial for E-602, the First Ever Glyco-Immune Checkpoint Inhibitor Businesswire
18-Apr-2023 TME Pharma Announces Successful €2 Million Financing and the End of the Convertible Bond Program With a Lock-Up of New Shares and Lock-Up of Bond Conversions Extending Financial Runway Into December 2023 Businesswire
18-Apr-2023 AHF Applauds Ghana for Approving Malaria Vaccine, Urges WHO Approval after Trials Businesswire
18-Apr-2023 More Than 150 Million Americans Now Have Insurance Coverage for Kerecis’ Medical-Fish-Skin Wound Treatment Businesswire